K-C Suspension Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with K-C Suspension
L
- L-Mycin (lincomycin)
- labetalol
- Lanoxicaps (digoxin)
- Lanoxin (digoxin)
- Lescol (fluvastatin)
- Lescol XL (fluvastatin)
- leucovorin / pyrimethamine
- Levall 5.0 (guaifenesin / hydrocodone / phenylephrine)
- Levaquin (levofloxacin)
- Levaquin Leva-Pak (levofloxacin)
- Levatol (penbutolol)
- Levo-Dromoran (levorphanol)
- levofloxacin
- levomethadyl acetate
- levorphanol
- Lexuss 210 (chlorpheniramine / codeine)
- lidocaine / oxytetracycline
- Lincocin (lincomycin)
- lincomycin
- Lincorex (lincomycin)
- Lipitor (atorvastatin)
- Liptruzet (atorvastatin / ezetimibe)
- Liquicet (acetaminophen / hydrocodone)
- Liquicough HC (chlorpheniramine / hydrocodone / phenylephrine)
- Liquihistine CS (brompheniramine / codeine / phenylpropanolamine)
- Liquituss HD (hydrocodone / pseudoephedrine)
- Liquitussin HC Syrup (chlorpheniramine / hydrocodone / phenylephrine)
- Logen (atropine / diphenoxylate)
- Lomanate (atropine / diphenoxylate)
- lomefloxacin
- Lomocot (atropine / diphenoxylate)
- Lomotil (atropine / diphenoxylate)
- Lonox (atropine / diphenoxylate)
- Lopressor (metoprolol)
- Lopressor HCT (hydrochlorothiazide / metoprolol)
- Lopurin (allopurinol)
- Lorcet (acetaminophen / hydrocodone)
- Lorcet 10 / 650 (acetaminophen / hydrocodone)
- Lorcet HD (acetaminophen / hydrocodone)
- Lorcet Plus (acetaminophen / hydrocodone)
- Lortab (acetaminophen / hydrocodone)
- Lortab ASA (aspirin / hydrocodone)
- Lortuss EX (codeine / guaifenesin / pseudoephedrine)
- Lortuss HC (hydrocodone / phenylephrine)
- lovastatin
- lovastatin / niacin
- LymePak (doxycycline)
- Lypqozet (atorvastatin / ezetimibe)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.